Health & Life Sciences

Saudi Arabia 2019 - Health and Life Sciences

Saudi Arabia’s health sector is currently facing a combination of demand-led growth and major structural change as the government seeks to privatise hospitals and other medical service providers. The interplay of these two forces is likely to have an influence on the sector in the coming years. Since 2016 two primary strategy documents have been guiding health care policies: the National Transformation Programme, which runs until 2020, and the Vision 2030 development blueprint. The former calls for increased private sector participation in the health sector, while the latter is an overall strategic plan for the country that highlights the need to modernise and diversify the economy. This chapter contains an interview with Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority.

Cover of The Report: Saudi Arabia 2019

The Report

This chapter is from the Saudi Arabia 2019 report. Explore other chapters from this report.

Interviews & Viewpoints

Sketch of Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority (SFDA)
Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority (SFDA) : Interview

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart